We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$20.7B
Cap. Flow
-$1.83B
Cap. Flow %
-1.91%
Top 10 Hldgs %
18.42%
Holding
4,634
New
1,015
Increased
1,222
Reduced
1,970
Closed
108

Top Sells

Rank Stock Value
1
FXI icon
iShares China Large-Cap ETF
FXI
+$256M
2
C icon
Citigroup
C
+$159M
3
PCG icon
PG&E
PCG
+$138M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$132M
5
UBS icon
UBS Group
UBS
+$113M

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 16.32%
3 Financials 13.63%
4 Consumer Discretionary 9.13%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAD
4026
Teads Holding Co
TEAD
$79.8M
$0 ﹤0.01%
+32
New +$241
OCUL icon
4027
Ocular Therapeutix
OCUL
$1.88B
-61,043
Closed -$302K
IMDX
4028
Insight Molecular Diagnostics
IMDX
$161M
$0 ﹤0.01%
+2
New +$45
ODC icon
4029
Oil-Dri
ODC
$1.42B
$0 ﹤0.01%
+6
New +$79
OIS icon
4030
Oil States International
OIS
$507M
$0 ﹤0.01%
+12
New +$84
OLMA icon
4031
Olema Pharmaceuticals
OLMA
$1.01B
$0 ﹤0.01%
+14
New +$44
OOMA icon
4032
Ooma
OOMA
$594M
$0 ﹤0.01%
+23
New +$305
OPFI icon
4033
OppFi
OPFI
$831M
$0 ﹤0.01%
+65
New +$209
ORC
4034
Orchid Island Capital
ORC
$1.28B
$0 ﹤0.01%
12
-2,078
-99% -$30.9K
ORIC icon
4035
Oric Pharmaceuticals
ORIC
$1.33B
$0 ﹤0.01%
17
-17,744
-100% -$70.8K
ORMP icon
4036
Oramed Pharmaceuticals
ORMP
$180M
$0 ﹤0.01%
20
-20,789
-100% -$111K
ORRF icon
4037
Orrstown Financial Services
ORRF
$851M
$0 ﹤0.01%
+11
New +$263
OTLK icon
4038
Outlook Therapeutics
OTLK
$191M
$0 ﹤0.01%
+1
New +$29
OTRK
4039
DELISTED
Ontrak
OTRK
0
OXLC
4040
Oxford Lane Capital
OXLC
$893M
$0 ﹤0.01%
+5
New +$164
PALI icon
4041
Palisade Bio
PALI
$367M
0
PASG icon
4042
Passage Bio
PASG
$14.8M
$0 ﹤0.01%
1
-911
-100% -$42.6K
PBFS icon
4043
Pioneer Bancorp
PBFS
$433M
$0 ﹤0.01%
+12
New +$122
PBYI icon
4044
Puma Biotechnology
PBYI
$409M
$0 ﹤0.01%
+17
New +$42
PCB icon
4045
PCB Bancorp
PCB
$395M
$0 ﹤0.01%
+6
New +$122
PCYO icon
4046
Pure Cycle
PCYO
$254M
$0 ﹤0.01%
+19
New +$205
PEJ icon
4047
Invesco Leisure and Entertainment ETF
PEJ
$255M
-4,270
Closed -$208K
PEPG icon
4048
PepGen
PEPG
$136M
$0 ﹤0.01%
+4
New +$45
PFIS icon
4049
Peoples Financial Services
PFIS
$717M
$0 ﹤0.01%
+7
New +$356
PIII icon
4050
P3 Health Partners
PIII
$34M
$0 ﹤0.01%
+1
New +$279

Similar funds

Credit Suisse's Q2 2022 Portfolio in Review

As of Q2 2022, Credit Suisse held 4,634 positions worth $96.1B, down 18% from $117B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Credit Suisse's Q2 2022 filing shows 1,015 new, 1,222 increased, 1,970 reduced and 108 closed positions. Its largest new stake was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M. The largest sale was iShares China Large-Cap ETF, an estimated $256M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q2 2022 buy was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $278M increase.
  • Credit Suisse's biggest Q2 2022 reduction was iShares China Large-Cap ETF, cutting an estimated $256M.
  • Credit Suisse fully exited Cerner Corp in Q2 2022, selling an estimated $46M.
  • Credit Suisse's ten largest holdings make up 18% of its $96.1B portfolio in Q2 2022.
  • Credit Suisse opened 1,015 new positions and closed 108 in Q2 2022.
  • Credit Suisse's portfolio value fell 18% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.